MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 159 filers reported holding MERSANA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,426 | -89.9% | 42,068 | -73.8% | 0.00% | -100.0% |
| Q2 2023 | $527,397 | +6013.3% | 160,303 | +7537.1% | 0.00% | – |
| Q1 2023 | $8,627 | +72.5% | 2,099 | +182.9% | 0.00% | – |
| Q3 2022 | $5,000 | -44.4% | 742 | -63.3% | 0.00% | – |
| Q2 2022 | $9,000 | -87.5% | 2,023 | -88.8% | 0.00% | – |
| Q1 2022 | $72,000 | +800.0% | 18,123 | +1269.8% | 0.00% | – |
| Q4 2021 | $8,000 | -77.8% | 1,323 | -65.6% | 0.00% | – |
| Q3 2021 | $36,000 | -75.0% | 3,849 | -56.6% | 0.00% | – |
| Q1 2021 | $144,000 | +34.6% | 8,870 | +121.4% | 0.00% | – |
| Q4 2020 | $107,000 | – | 4,007 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 796,458 | $14,830,000 | 12.35% |
| Consonance Capital Management LP | 3,468,171 | $64,577,000 | 7.87% |
| Sarissa Capital Management LP | 2,837,000 | $52,824,000 | 6.22% |
| Bain Capital Life Sciences Investors, LLC | 3,445,667 | $64,158,000 | 5.98% |
| Ghost Tree Capital, LLC | 1,050,000 | $19,551,000 | 5.65% |
| NEA Management Company, LLC | 5,959,520 | $110,966,000 | 4.70% |
| Soleus Capital Management, L.P. | 393,041 | $7,318,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 667,500 | $12,429,000 | 3.38% |
| Avoro Capital Advisors LLC | 6,800,000 | $126,616,000 | 1.80% |
| FNY Investment Advisers, LLC | 199,800 | $3,720,000 | 1.57% |